A Prospective Phase II Study of Induction Erlotinib Therapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)32039-1 ◽

2012 ◽

Vol 23 ◽

pp. xi43

Author(s):

W.-Z. Zhong ◽

X.-N. Yang ◽

R.-Q. Liao ◽

Q. Nie ◽

J. Su ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Prospective Phase ◽

Erlotinib Therapy

Download Full-text

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.006 ◽

2021 ◽

Author(s):

Akira Hamada ◽

Junichi Soh ◽

Akito Hata ◽

Kiyoshi Nakamatsu ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Adjuvant Immunotherapy

Download Full-text

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study

The Oncologist ◽

10.1634/theoncologist.2018-0120 ◽

2018 ◽

Vol 24 (2) ◽

pp. 157 ◽

Author(s):

Liwen Xiong ◽

Rong Li ◽

Jiayuan Sun ◽

Yuqing Lou ◽

Weiyan Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

European Journal of Cancer ◽

10.1016/j.ejca.2006.01.049 ◽

2006 ◽

Vol 42 (10) ◽

pp. 1399-1406 ◽

Author(s):

B. Biesma ◽

C. Manegold ◽

H.J.M. Smit ◽

L. Willems ◽

C. Legrand ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

European Organization

Download Full-text

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Radiotherapy and Oncology ◽

10.1016/j.radonc.2008.07.019 ◽

2008 ◽

Vol 88 (3) ◽

pp. 359-367 ◽

Author(s):

Pia Baumann ◽

Jan Nyman ◽

Morten Hoyer ◽

Giovanna Gagliardi ◽

Ingmar Lax ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Stereotactic Body Radiotherapy ◽

Phase Ii Study ◽

Stage I ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study

Cancer Management and Research ◽

10.2147/cmar.s189287 ◽

2019 ◽

Vol Volume 11 ◽

pp. 6543-6552 ◽

Author(s):

Zhiwei Chen ◽

Shengping Shen ◽

Wenbo Shi ◽

Gening Jiang ◽

Xin Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

Phase II study of neoadjuvant chemotherapy with paclitaxel and cisplatin in Stage IIIA N2 non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7305 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7305-7305 ◽

Author(s):

I. S. Choi ◽

D. Y. Oh ◽

D. W. Kim ◽

Y. T. Kim ◽

T. Y. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): A report of the 2 year and median survival (MS) for the RTOG 0324 trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7516 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7516-7516 ◽

Author(s):

G. R. Blumenschein ◽

R. Paulus ◽

W. J. Curran ◽

F. Robert ◽

F. V. Fossella ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Median Survival ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

A Prospective Phase II Study of Induction Carboplatin and Vinorelbine followed by Concomitant Topotecan and Accelerated Radiotherapy (ART) in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318145b2e5 ◽

2007 ◽

Vol 2 (9) ◽

pp. 831-837 ◽

Author(s):

Samir H. Patel ◽

Munther Ajlouni ◽

Robert Chapman ◽

Mei Lu ◽

Benjamin Movsas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell Lung ◽

Accelerated Radiotherapy ◽

Prospective Phase

Download Full-text

FP10.05 A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.127 ◽

2021 ◽

Vol 16 (3) ◽

pp. S216-S217

Author(s):

K. Ma ◽

Y. Xu ◽

Y. Cai ◽

X. Wang ◽

C. Sun ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Prospective Phase ◽

Pretreated Patients

Download Full-text

P2.02-037 Final Results of Prospective Phase II Study of Adding Erlotinib to Chemoradiation for patients with Stage III Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1184 ◽

2017 ◽

Vol 12 (1) ◽

pp. S870

Author(s):

Ritsuko Komaki ◽

Pamela Allen ◽

Xiong Wei ◽

George Blumenschein ◽

Xi Ming Tang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Stage Iii ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text